Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes

FEBS Lett. 2008 Jun 25;582(15):2291-8. doi: 10.1016/j.febslet.2008.05.029. Epub 2008 Jun 2.

Abstract

The effect of oxLDL on CD36 expression has been assessed in preadipocytes induced to differentiate. Novel evidence is provided that oxLDL induce a peroxisome proliferator-activated receptor gamma-independent CD36 overexpression, by up-regulating nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2). The nuclear translocation of Nrf2 appeared to depend on PKC pathway activation. In adipocytes, the CD36 up-regulation may indicate a compensation mechanism to meet the demand of excess oxLDL and oxidised lipids in blood, reducing the risk of atherogenesis. Besides strengthening the hypothesis that oxLDL can contribute to the onset of insulin-resistance, data herein presented highlight the significance of oxLDL-induced CD36 overexpression within the cellular defence response.

MeSH terms

  • 3T3-L1 Cells
  • Active Transport, Cell Nucleus
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Animals
  • CD36 Antigens / genetics
  • CD36 Antigens / metabolism*
  • Cell Differentiation
  • Lipoproteins, LDL / metabolism*
  • Lipoproteins, LDL / pharmacology
  • Mice
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism*
  • PPAR gamma / metabolism
  • RNA Interference
  • Up-Regulation

Substances

  • CD36 Antigens
  • Lipoproteins, LDL
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • PPAR gamma
  • oxidized low density lipoprotein